GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (OTCPK:RADCQ) » Definitions » Beneish M-Score

Rite Aid (Rite Aid) Beneish M-Score : -3.06 (As of Apr. 25, 2024)


View and export this data going back to 1970. Start your Free Trial

What is Rite Aid Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.06 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Rite Aid's Beneish M-Score or its related term are showing as below:

RADCQ' s Beneish M-Score Range Over the Past 10 Years
Min: -3.2   Med: -2.58   Max: 0.06
Current: -3.06

During the past 13 years, the highest Beneish M-Score of Rite Aid was 0.06. The lowest was -3.20. And the median was -2.58.


Rite Aid Beneish M-Score Historical Data

The historical data trend for Rite Aid's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid Beneish M-Score Chart

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.39 -3.20 -2.37 -2.94 -2.90

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.74 -2.96 -2.90 -2.86 -3.06

Competitive Comparison of Rite Aid's Beneish M-Score

For the Pharmaceutical Retailers subindustry, Rite Aid's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rite Aid's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Rite Aid's Beneish M-Score falls into.



Rite Aid Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Rite Aid for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9709+0.528 * 1.0107+0.404 * 0.4224+0.892 * 0.9697+0.115 * 0.8797
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0882+4.679 * -0.04306-0.327 * 1.2225
=-3.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Aug23) TTM:Last Year (Aug22) TTM:
Total Receivables was $1,473 Mil.
Revenue was 5646.081 + 5653.162 + 6092.902 + 6083.346 = $23,475 Mil.
Gross Profit was 1095.596 + 1178.526 + 1248.964 + 1203.752 = $4,727 Mil.
Total Current Assets was $3,739 Mil.
Total Assets was $7,126 Mil.
Property, Plant and Equipment(Net PPE) was $3,029 Mil.
Depreciation, Depletion and Amortization(DDA) was $273 Mil.
Selling, General, & Admin. Expense(SGA) was $5,204 Mil.
Total Current Liabilities was $6,518 Mil.
Long-Term Debt & Capital Lease Obligation was $2,386 Mil.
Net Income was -1020.03 + -306.718 + -241.311 + -67.144 = $-1,635 Mil.
Non Operating Income was -582.164 + -163.308 + -149.306 + -19.444 = $-914 Mil.
Cash Flow from Operations was -440.623 + -372.538 + 266.413 + 132.609 = $-414 Mil.
Total Receivables was $1,564 Mil.
Revenue was 5901.069 + 6014.583 + 6065.39 + 6228.88 = $24,210 Mil.
Gross Profit was 1154.495 + 1196.729 + 1241.313 + 1334.383 = $4,927 Mil.
Total Current Assets was $3,741 Mil.
Total Assets was $8,367 Mil.
Property, Plant and Equipment(Net PPE) was $3,630 Mil.
Depreciation, Depletion and Amortization(DDA) was $285 Mil.
Selling, General, & Admin. Expense(SGA) was $4,932 Mil.
Total Current Liabilities was $2,819 Mil.
Long-Term Debt & Capital Lease Obligation was $5,733 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1472.755 / 23475.491) / (1564.388 / 24209.922)
=0.062736 / 0.064618
=0.9709

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4926.92 / 24209.922) / (4726.838 / 23475.491)
=0.203508 / 0.201352
=1.0107

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3738.653 + 3029.044) / 7125.952) / (1 - (3740.864 + 3630.462) / 8367.125)
=0.050275 / 0.119013
=0.4224

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=23475.491 / 24209.922
=0.9697

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(284.605 / (284.605 + 3630.462)) / (272.87 / (272.87 + 3029.044))
=0.072695 / 0.08264
=0.8797

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5204.294 / 23475.491) / (4932.243 / 24209.922)
=0.221691 / 0.203728
=1.0882

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2385.671 + 6517.954) / 7125.952) / ((5733.14 + 2818.767) / 8367.125)
=1.249465 / 1.022084
=1.2225

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1635.203 - -914.222 - -414.139) / 7125.952
=-0.04306

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Rite Aid has a M-score of -3.06 suggests that the company is unlikely to be a manipulator.


Rite Aid Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Rite Aid's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (Rite Aid) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Executives
Christopher W. Dupaul officer: Chief Operating Officer 1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112
Sabatino Thomas J Jr officer: Chief Legal Officer C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Steven Bixler officer: Chief Accounting Officer C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Heyward R Donigan officer: Chief Executive Officer 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Jocelyn Z Konrad officer: Executive VP RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011
Ray Smithberger officer: SVP, Operations 30 HUNTER LANE, CAMP HILL PA 17011
Bari A Harlam director C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003
Paul D Gilbert officer: EVP, Secretary&General Counsel 103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Andre Persaud officer: EVP, Retail 30 HUNTER LANE, CAMP HILL PA 17011
Dan Robson officer: President, EnvisionRXOptions 30 HUNTER LANE, CAMP HILL PA 17011
James J Peters officer: Chief Operating Officer C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843
James J Comitale officer: EVP, General Counsel, Secy. 30 HUNTER LANE, CAMP HILL PA 17011
Jessica Kazmaier officer: EVP, Chief HR Officer 30 HUNTER LANE, CAMP HILL PA 17011
Justin L. Mennen officer: EVP, Chief Information Officer 30 HUNTER LANE, CAMP HILL PA 17011
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402